These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32969224)

  • 1. Analysis of the Association between Fatigue and the Plasma Lipidomic Profile of Inflammatory Bowel Disease Patients.
    Horta D; Moreno-Torres M; Ramírez-Lázaro MJ; Lario S; Kuligowski J; Sanjuan-Herráez JD; Quintas G; Villoria A; Calvet X
    J Proteome Res; 2021 Jan; 20(1):381-392. PubMed ID: 32969224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mass spectrometry-based comprehensive lipidomic analysis of plasma from patients with inflammatory bowel disease.
    Iwatani S; Iijima H; Otake Y; Amano T; Tani M; Yoshihara T; Tashiro T; Tsujii Y; Inoue T; Hayashi Y; Takeda K; Hayashi A; Fujita S; Shinzaki S; Takehara T
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1355-1364. PubMed ID: 32285970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UPLC-QTOF-MS-Based Plasma Lipidomic Profiling Reveals Biomarkers for Inflammatory Bowel Disease Diagnosis.
    Guan S; Jia B; Chao K; Zhu X; Tang J; Li M; Wu L; Xing L; Liu K; Zhang L; Wang X; Gao X; Huang M
    J Proteome Res; 2020 Feb; 19(2):600-609. PubMed ID: 31821004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic and lipidomic biomarkers in the diagnosis and progression of inflammatory bowel disease - a review.
    Cecerska-Heryć E; Ronkowski B; Heryć R; Serwin N; Grygorcewicz B; Roszak M; Galant K; Dołęgowska B
    Proteomics Clin Appl; 2023 Jan; 17(1):e2200003. PubMed ID: 36043901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Fecal Microbiomes and Serum Metabolomes of Fatigued Patients With Quiescent Inflammatory Bowel Diseases.
    Borren NZ; Plichta D; Joshi AD; Bonilla G; Peng V; Colizzo FP; Luther J; Khalili H; Garber JJ; Janneke van der Woude C; Sadreyev R; Vlamakis H; Xavier RJ; Ananthakrishnan AN
    Clin Gastroenterol Hepatol; 2021 Mar; 19(3):519-527.e5. PubMed ID: 32184182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort.
    Romberg-Camps MJ; Bol Y; Dagnelie PC; Hesselink-van de Kruijs MA; Kester AD; Engels LG; van Deursen C; Hameeteman WH; Pierik M; Wolters F; Russel MG; Stockbrügger RW
    Inflamm Bowel Dis; 2010 Dec; 16(12):2137-47. PubMed ID: 20848468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatigue in a population-based cohort of patients with inflammatory bowel disease 20 years after diagnosis: The IBSEN study.
    Huppertz-Hauss G; Høivik ML; Jelsness-Jørgensen LP; Opheim R; Henriksen M; Høie O; Hovde Ø; Kempski-Monstad I; Solberg IC; Jahnsen J; Hoff G; Moum B; Bernklev T
    Scand J Gastroenterol; 2017 Mar; 52(3):351-358. PubMed ID: 27852169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of metabolic and lipid profiling in inflammatory bowel diseases: A pilot study.
    Tefas C; Ciobanu L; Tanțău M; Moraru C; Socaciu C
    Bosn J Basic Med Sci; 2020 May; 20(2):262-270. PubMed ID: 31368421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
    Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
    World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in fatigue over 2 years are associated with activity of inflammatory bowel disease and psychological factors.
    Graff LA; Clara I; Walker JR; Lix L; Carr R; Miller N; Rogala L; Bernstein CN
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1140-6. PubMed ID: 23602816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic interobserver variability in Crohn's disease- and ulcerative colitis-associated dysplasia: a multicenter digital survey from the IG-IBD Pathologists Group.
    Leoncini G; Donato F; Reggiani-Bonetti L; Salviato T; Cadei M; Daperno M; Principi MB; Armuzzi A; Caprioli F; Canavese G; Villanacci V;
    Tech Coloproctol; 2021 Jan; 25(1):101-108. PubMed ID: 33025294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Italian cohort of patients affected by inflammatory bowel disease is characterised by variation in glycerophospholipid, free fatty acids and amino acid levels.
    Murgia A; Hinz C; Liggi S; Denes J; Hall Z; West J; Santoru ML; Piras C; Manis C; Usai P; Atzori L; Griffin JL; Caboni P
    Metabolomics; 2018 Oct; 14(10):140. PubMed ID: 30830399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipidomic Profiling in Inflammatory Bowel Disease: Comparison Between Ulcerative Colitis and Crohn's Disease.
    Fan F; Mundra PA; Fang L; Galvin A; Moore XL; Weir JM; Wong G; White DA; Chin-Dusting J; Sparrow MP; Meikle PJ; Dart AM
    Inflamm Bowel Dis; 2015 Jul; 21(7):1511-8. PubMed ID: 25895111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of minichromosome maintenance protein 2 in active inflammatory bowel disease.
    Davies RJ; Scott IS; Morris LS; Rushbrook SM; Bird K; Vowler SL; Arends M; Miller R; Coleman N
    Colorectal Dis; 2004 Mar; 6(2):103-10. PubMed ID: 15008907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatigue in inflammatory bowel diseases: relationship with age and disease activity.
    Pellino G; Sciaudone G; Caserta V; Candilio G; De Fatico GS; Gagliardi S; Landino I; Patturelli M; Riegler G; Di Caprio EL; Canonico S; Gritti P; Selvaggi F
    Int J Surg; 2014; 12 Suppl 2():S60-S63. PubMed ID: 25159230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis.
    Tanaka M; Riddell RH; Saito H; Soma Y; Hidaka H; Kudo H
    Scand J Gastroenterol; 1999 Jan; 34(1):55-67. PubMed ID: 10048734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
    Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
    Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
    Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
    Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.